

[ Tue, May 07th 2024
] - WOPRAI
[ Tue, May 07th 2024
] - WOPRAI
[ Tue, May 07th 2024
] - WOPRAI
[ Tue, May 07th 2024
] - WOPRAI
[ Tue, May 07th 2024
] - WOPRAI
[ Tue, May 07th 2024
] - WOPRAI
[ Tue, May 07th 2024
] - WOPRAI
[ Tue, May 07th 2024
] - WOPRAI
[ Tue, May 07th 2024
] - WOPRAI

[ Mon, May 06th 2024
] - WOPRAI
[ Mon, May 06th 2024
] - WOPRAI
[ Mon, May 06th 2024
] - WOPRAI
[ Mon, May 06th 2024
] - WOPRAI
[ Mon, May 06th 2024
] - WOPRAI
[ Mon, May 06th 2024
] - WOPRAI
[ Mon, May 06th 2024
] - WOPRAI
[ Mon, May 06th 2024
] - WOPRAI
[ Mon, May 06th 2024
] - WOPRAI
[ Mon, May 06th 2024
] - WOPRAI
[ Mon, May 06th 2024
] - WOPRAI
[ Mon, May 06th 2024
] - WOPRAI
[ Mon, May 06th 2024
] - WOPRAI
[ Mon, May 06th 2024
] - WOPRAI
[ Mon, May 06th 2024
] - WOPRAI
[ Mon, May 06th 2024
] - WOPRAI
[ Mon, May 06th 2024
] - WOPRAI
[ Mon, May 06th 2024
] - WOPRAI
[ Mon, May 06th 2024
] - WOPRAI
[ Mon, May 06th 2024
] - WOPRAI
[ Mon, May 06th 2024
] - WOPRAI
Sung Ji Nam Maintained (TWST) at Buy with Increased Target to $48 on, May 6th, 2024
Sung Ji Nam of Scotiabank, Maintained "Twist Bioscience Corporation" (TWST) at Buy with Increased Target from $43 to $48 on, May 6th, 2024.
Sung has made no other calls on TWST in the last 4 months.
There are 4 other peers that have a rating on TWST. Out of the 4 peers that are also analyzing TWST, 0 agree with Sung's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Sung
- Catherine Ramsey of "Baird" Maintained at Buy with Increased Target to $40 on, Friday, May 3rd, 2024
- Luke Sergott of "Barclays" Maintained at Buy with Increased Target to $45 on, Friday, May 3rd, 2024
- Vijay Kumar of "Evercore ISI Group" Maintained at Buy with Increased Target to $50 on, Friday, May 3rd, 2024
- Matthew Sykes of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $45 on, Thursday, January 18th, 2024
Contributing Sources